Civil Litigation,
Government,
Antitrust & Trade Reg.
Jul. 30, 2019
State settles pay-to-delay antitrust claim with pharmaceutical companies
Three drugmakers reached a nearly $70 million settlement with California Monday over anticompetitive practices in which they paid to delay the release of more affordable generic drugs.
SAN FRANCISCO -- Three drugmakers reached a nearly $70 million settlement with California Monday over anticompetitive practices in which they paid to delay the release of more affordable generic drugs.
State Attorney General Xavier Becerra said the settlement was the largest by any state for "pay-for-delay" allegations against the companies, and the only one to have secured injunctions prohibiting similar misconduct in the future. ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In